ADIAL PHARMACEUTICALS, INC.

Nasdaq:ADIL

Pharmaceutical Preparations·CHARLOTTESVILLE, VA

CEO

Claiborne Cary J

CFO

Shah Vinay

Financials

20 shown

Type	Period	Ended	Filed
10-K	FY 2025	12/31/25	3/5/26	→
10-Q	Q3 2025	9/30/25	11/13/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/14/25	→
10-K	FY 2024	12/31/24	3/4/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
↓

Earnings Releases (8-K)

12 shown

Filed	Period
3/6/26	Q1 FY2026	→
11/14/25	Q4 FY2025	→
8/14/25	Q3 FY2025	→
5/15/25	Q2 FY2025	→
3/4/25	Q1 FY2025	→
11/14/23	Q4 FY2023	→
↓

News (8-K)

68 shown

Filed	Type	Description
3/3/26	Reg FD	Regulation FD Disclosure	→
2/24/26	Other	Other Events	→
2/4/26	Other	Material Modification to Rights of Security Holders	→
1/6/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
12/1/25	Agreement	Entry into a Material Definitive Agreement	→
9/16/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
12/19/25	424B5	PROSPECTUS SUPPLEMENT	→
12/12/25	S-3	REGISTRATION STATEMENT	→
9/9/25	S-8	REGISTRATION STATEMENT	→
8/1/25	424B5	PROSPECTUS SUPPLEMENT	→
7/31/25	424B5	PROSPECTUS SUPPLEMENT	→
6/18/25	424B5	424B5	→
↓

Filing History(522 filings)

TypeDateAccessionPeriodSize

8-K

Mar 6, 2026

0001213900-26-024336CURRENT REPORT

Mar 6, 2026

257.9 KB

10-K

Mar 5, 2026

0001213900-26-024175ANNUAL REPORT

Dec 31, 2025

5.7 MB

8-K

Mar 3, 2026

0001213900-26-022718CURRENT REPORT

Feb 26, 2026

226.6 KB

8-K

Feb 24, 2026

0001213900-26-019639CURRENT REPORT

Feb 23, 2026

219.3 KB

SCHEDULE 13G

Feb 18, 2026

0001172661-26-001297

—

10.4 KB

8-K

Feb 4, 2026

0001213900-26-012274CURRENT REPORT

Feb 3, 2026

231.1 KB

8-K

Jan 6, 2026

0001213900-26-001790CURRENT REPORT

Jan 5, 2026

182.9 KB

DEF 14A

Jan 6, 2026

0001213900-26-001792DEFINITIVE PROXY STATEMENT

Feb 26, 2026

632.4 KB

PRE 14A

Dec 23, 2025

0001213900-25-125283PRELIMINARY PROXY STATEMENT

Dec 23, 2025

148.4 KB

424B5

Dec 19, 2025

0001213900-25-123940PROSPECTUS SUPPLEMENT

—

160.2 KB

EFFECT

Dec 17, 2025

9999999995-25-003812

—

1.9 KB

S-3

Dec 12, 2025

0001213900-25-121198REGISTRATION STATEMENT

—

415.0 KB

Dec 3, 2025

0001213900-25-117804

—

12.3 KB

8-K

Dec 1, 2025

0001213900-25-116666CURRENT REPORT

Nov 25, 2025

420.9 KB

8-K

Nov 14, 2025

0001213900-25-110385CURRENT REPORT

Nov 14, 2025

238.4 KB

10-Q

Nov 13, 2025

0001213900-25-109979QUARTERLY REPORT

Sep 30, 2025

3.9 MB

8-K

Sep 16, 2025

0001213900-25-087925CURRENT REPORT

Sep 16, 2025

230.1 KB

S-8

Sep 9, 2025

0001213900-25-086182REGISTRATION STATEMENT

—

225.2 KB

8-K

Sep 3, 2025

0001213900-25-083719CURRENT REPORT

Sep 2, 2025

223.8 KB

8-K

Aug 14, 2025

0001213900-25-076085CURRENT REPORT

Aug 14, 2025

234.0 KB

10-Q

Aug 13, 2025

0001213900-25-075695QUARTERLY REPORT

Jun 30, 2025

3.8 MB

424B5

Aug 1, 2025

0001213900-25-070697PROSPECTUS SUPPLEMENT

—

475.4 KB

8-K

Aug 1, 2025

0001213900-25-070671CURRENT REPORT

Jul 31, 2025

528.5 KB

8-K

Aug 1, 2025

0001213900-25-070642CURRENT REPORT

Aug 1, 2025

233.2 KB

424B5

Jul 31, 2025

0001213900-25-069975PROSPECTUS SUPPLEMENT

—

14.3 KB

25 filings shown

ADIAL PHARMACEUTICALS, INC.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(522 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
1/6/26	DEF 14A	DEFINITIVE PROXY STATEMENT	→
12/23/25	PRE 14A	PRELIMINARY PROXY STATEMENT	→
6/27/25	DEFR14A	DEFR14A	→
6/10/25	DEF 14A	DEF 14A	→
5/23/25	PRE 14A	PRE 14A	→
9/27/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
6/2/25	4	4	→
6/2/25	4	4	→
6/2/25	4	4	→
6/2/25	4	4	→
6/2/25	4	4	→
6/2/25	4	4	→
↓

Filed	Form	Description
2/18/26	SCHEDULE 13G	SCHEDULE 13G	→
12/17/25	EFFECT	EFFECT	→
12/3/25	D	D	→
6/23/25	SCHEDULE 13G	SCHEDULE 13G	→
6/17/25	PRER14A	PRER14A	→
6/16/25	EFFECT	EFFECT	→
↓